CVN766 is a novel and highly selective SORA1 currently being evaluated in clinical trials for schizophrenia overactivation of OX1R is associated with positive symptoms of schizophrenia (such as hallucinations, delusions) and cognitive impairment. The gene discussed is HCRTR1; the disease is schizophrenia.